Retatrutide is a once-weekly triple-receptor injection that delivers up to 30% body weight loss while showing promise against Alzheimers, fatty liver disease, visceral fat, and cardiovascular risks
Es un compuesto en investigacin, no aprobado por la FDA ni la COFEPRIS para uso teraputico, y est prohibido en el deporte profesional (WADA)
These medications trigger insulin production, lowering blood sugar levels, which is why they are often used to treat type 2 diabetes
Regarding eGFR trajectories, both drugs induced a slightly slower decline in eGFR compared to the placebo groups, which was more pronounced in people with moderate (eGFR 3059 mL/min/1.73 m 2 ) or severe (eGFR 50%, reaching ESKD, death from kidney disease or death from CVD
How to start GLP-1 treatment in Singapore In Singapore, GLP-1 medications are prescription-only medicines regulated by the Health Sciences Authority (HSA)